Doctors Reach Pancreatic Tumor Through a Vein to Diagnose and Treat It
A case report describes a novel transjugular endovascular biopsy through the portal vein that diagnosed pancreatic cancer after standard biopsies ...
A case report describes a novel transjugular endovascular biopsy through the portal vein that diagnosed pancreatic cancer after standard biopsies ...
A new systematic review and meta-analysis of 27 studies finds no consistent link between oral contraceptives, menopausal hormone therapy, or ...
A new review proposes a Dynamic Precision Oncology framework that monitors pancreatic cancer's evolving resistance mechanisms through longitudinal genomic, liquid ...
The PACT-21/CASSANDRA phase 3 trial found that six months of preoperative chemotherapy produced event-free survival comparable to a four-month preoperative ...
A new review maps the fast-moving landscape of next-generation KRAS inhibitors, degraders, and combination strategies now advancing beyond the first ...
The phase 1 GlutaPanc trial shows that l-glutamine can be safely combined with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ...
A new perspective argues that radiation must be redesigned as an immunological platform to finally unlock the potential of combined ...
A new computational platform reveals how collagen architecture and myeloid cells cooperate to trap therapeutic T cells in pancreatic tumors, ...
Pancreatic cancer has long been one of medicine's most stubborn adversaries, a disease so aggressive and so difficult to detect ...
Pancreatic cancer has earned its grim reputation the hard way. Fewer than one in eight patients survives five years beyond ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine